Libra Infusions Limited (DSE: LIBRAINFU)
Health Care · Pharmaceuticals · BD
Tk611.80
-2.80% today · -20.4% 1Y
Libra Infusions Limited (DSE: LIBRAINFU) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.27M.
Over the last twelve months the share price has lost 20.4%, trading between 547.10 and 850.00.
Tweenvest scores Libra Infusions Limited across four factors: quality 46/100, value 42/100, growth 0/100. Its strongest factor is quality.
LIBRAINFU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.27M
- Revenue (TTM)
- $2.33M
- P/E
- —
- EPS
- 0.70
- Dividend yield
- —
- Beta (5Y)
- -0.30
- 52-week high
- Tk850.00
- 52-week low
- Tk547.10
- Avg volume (3M)
- —
- Shares outstanding
- 2.25M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,249.17 | -0.50% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.98 | +1.01% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.50 | -1.35% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.05 | -0.09% |
Figures last refreshed Aug 18, 2026.